MD REPORTS
Subscribe
Sign in
Home
Archive
Leaderboard
About
Latest
Top
Discussions
BREAKING: CDC snubs Moderna’s new mRNA flu vaccine
Just weeks after a controversial FDA approval, Moderna’s mFLUSIVA vaccine is conspicuously absent from CDC’s guidance for the coming flu season.
6 hrs ago
•
Maryanne Demasi, PhD
64
6
17
The journal Vaccine has an impartiality problem
It was once the flagship journal of vaccinology. Now, Vaccine has undergone a striking editorial shift. This investigation examines what changed — and…
Sep 9
•
Maryanne Demasi, PhD
90
9
17
The antidepressant question we’re still afraid to ask
More than 20 years after the ABC deemed my documentary too controversial to air, the Lindsay Clancy trial has revived a question that remains taboo: can…
Sep 5
•
Maryanne Demasi, PhD
121
18
23
EXCLUSIVE: Is MIT’s vaccine safety study too risky for peer review?
MIT researchers found a potential safety signal in V-SAFE. A leading vaccine journal rejected the study without peer review—despite having published…
Sep 2
•
Maryanne Demasi, PhD
121
29
23
Four years!
Dear Readers,
Sep 1
•
Maryanne Demasi, PhD
97
13
6
August 2026
ACIP has been frozen for over 5 months - so who makes the decisions now?
FDA is still approving new vaccines while ACIP remains paralysed. The question is what happens next.
Aug 30
•
Maryanne Demasi, PhD
67
17
11
The Tamiflu scam
A randomised trial that should have been done decades ago has found more deaths among critically ill flu patients given Tamiflu than among those given…
Aug 27
•
Maryanne Demasi, PhD
180
29
23
MIT researchers uncover potential safety signal in CDC vaccine database
Nearly 2% of V-SAFE participants reported health deterioration lasting at least three months, which they attributed to Covid vaccination. The CDC has…
Aug 26
•
Maryanne Demasi, PhD
127
23
22
The evolution of the bribe
The old corruption in medicine relied on envelopes of cash and luxury junkets. The new version builds careers, shapes institutions, and influences…
Aug 24
•
Maryanne Demasi, PhD
170
18
30
Moderna’s melanoma ‘breakthrough’ is still science by press release
Everyone is celebrating a Phase III breakthrough in personalised mRNA cancer treatment—except nobody outside the companies has seen the data.
Aug 20
•
Maryanne Demasi, PhD
95
23
15
“They lied through their teeth” says US Senator
They claimed the US had the world’s best vaccine safety surveillance. But behind closed doors, the Acting FDA Commissioner warned Fauci it could miss…
Aug 17
•
Maryanne Demasi, PhD
183
23
37
Covid-19 vaccines and questions over miscarriage risk
Pregnant women were given sweeping assurances about Covid vaccine safety. But CDC data were flawed, animal studies raised questions, and officials…
Aug 13
•
Maryanne Demasi, PhD
178
19
32
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts